Cullinan Therapeutics, Inc. CGEM
11.31 USD -1.18 (-9.44%)
Nov 5, 2026, 2:15 PM EST
11.05 Day range 12.48
6.73 52-week range 23.19
- YTD
- +9.29%
- 1 year
- +54.74%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 241.65M | 196.92M | 191.09M | -144.65M | 86.90M | |
| 187.40M | 142.90M | 148.16M | 91.95M | 57.75M | |
| 54.25M | 54.02M | 42.49M | 40.19M | 29.15M | |
| -241.65M | -196.92M | -191.09M | 144.65M | -67.95M | |
| -219.88M | -167.38M | -153.16M | 111.21M | -65.57M | |
| -220.56M | -168.06M | -153.81M | 111.21M | -65.57M | |
| -220.56M | -168.06M | -153.81M | 111.21M | -65.57M | |
| -219.88M | -167.57M | -155.10M | 109.19M | -67.48M | |
| -3.36 | -2.78 | -3.21 | 2.46 | -1.52 | |
| -3.36 | -2.78 | -3.21 | 2.46 | -1.52 | |
| -3.36 | -2.78 | -3.21 | 2.38 | -1.52 | |
| -219.88M | -167.27M | -167.28M | 153.34M | -65.57M | |
| -219.88M | -167.27M | -167.28M | 153.34M | -65.57M | |
| 678.57K | 675.78K | 646.12K | 0 | 0 | |
| 59.05M | 53.77M | 41.55M | 45.16M | 43.08M | |
| 59.05M | 53.77M | 41.55M | 46.64M | 43.08M |